Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Forbes contributors publish independent expert analyses and insights. David Thomas Tao is an NYC-based spirits writer and media producer.

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Roche on Thursday said it would buy 89bio, the maker of an ...

Pro Football Hall of Famer and Miami Dolphins legend Dan Marino had a wake-up call in 2007 when he received a personal health diagnosis. Now, he’s sharing his journey to help others who may be ...

The whiskey delivers honey, burnt sugar, and smoky vanilla notes. Michter’s Distillery has announced the release of its US*1 Toasted Barrel Finish Sour Mash Whiskey. Set to arrive this September, the ...

GameSpot may get a commission from retail offers. A simple class that's also the most reckless, there's a skill curve to the best Terraria melee weapons. Instead of hiding behind a staff or bow, you ...

Tony Sachs has written for numerous publications about spirits and the people who make them since 2007, and traveled the globe to witness the processes firsthand. Michter’s has evolved from a defunct ...

GameSpot may get a commission from retail offers. Nearly 25 years from its initial release on the Nintendo Gamecube, Super Smash Bros. Melee continues to be one of the most popular games in the ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug approved in a severe form of fatty liver disease. Shortly after market close ...